Net sales of Libtayo , which is a top three selling product of Regeneron Pharmaceuticals in the U.S. , amounted to 175.7 million dollars in 2019 . The top selling drug for Regeneron in the U.S. was Eylea from 2017 to 2019 consecutively , generating sales of 4.6 billion U.S. dollars in 2019 .
